Apellis Pharmaceuticals
APLS
APLS
255 hedge funds and large institutions have $2.77B invested in Apellis Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 91 increasing their positions, 76 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1.12% less ownership
Funds ownership: 101.87% → 100.75% (-1.1%)
2% less funds holding
Funds holding: 260 → 255 (-5)
32% less capital invested
Capital invested by funds: $4.04B → $2.77B (-$1.28B)
Holders
255
Holding in Top 10
6
Calls
$26.6M
Puts
$19.8M
Top Buyers
| 1 | +$61.4M | |
| 2 | +$40.1M | |
| 3 | +$39.6M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$28M |
| 5 |
Man Group
London,
United Kingdom
|
+$27M |
Top Sellers
| 1 | -$41M | |
| 2 | -$40.5M | |
| 3 | -$25.2M | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$23.1M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$20M |